NCT03047317View on ClinicalTrials.gov

A Pharmacokinetic Study of MABp1 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

March 8, 2017

Study Completion Date

March 31, 2017

Conditions
Healthy
Interventions
BIOLOGICAL

MABp1

Single dose of intravenous MABp1

Trial Locations (1)

78705

XBiotech Investigative Site, Austin

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT03047317 - A Pharmacokinetic Study of MABp1 in Healthy Volunteers | Biotech Hunter | Biotech Hunter